{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:37:05Z","timestamp":1789472225738,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"RGUHS Advance research grant"},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR26240\/BRB\/10\/1626\/2017"],"award-info":[{"award-number":["BT\/PR26240\/BRB\/10\/1626\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2019\/005347"],"award-info":[{"award-number":["CRG\/2019\/005347"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic myeloid leukemia (CML) patients with complex chromosomal translocations as well as non-compliant CML patients often demonstrate short-lived responses and poor outcomes on the current therapeutic regimes using Imatinib and its variants. It has been derived so far that leukemic stem cells (LSCs) are responsible for Imatinib resistance and CML progression. Sonic hedgehog (Shh) signaling has been implicated in proliferation of this Imatinib-resistant CD34(+) LSCs. Our work here identifies the molecular mechanism of Shh-mediated mutation-independent Imatinib resistance that is most relevant for treating CML-variants and non-compliant patients. Our results elucidate that while Shh can impart stemness, it also upregulates expression of anti-apoptotic protein\u2014Bcl2. It is the upregulation of Bcl2 that is involved in conferring Imatinib resistance to the CD34(+) LSCs. Sub-toxic doses of Bcl2 inhibitor or Shh inhibitor (&lt;&lt;IC50), when used as adjuvants along with Imatinib, can re-sensitize Shh signaling cells to Imatinib. Our work here highlights the need to molecularly stratify CML patients and implement combinatorial therapy to overcome the current limitations and improve outcomes in CML.<\/jats:p>","DOI":"10.1038\/s41419-021-03542-w","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T13:03:15Z","timestamp":1615467795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exovesicular-Shh confers Imatinib resistance by upregulating Bcl2 expression in chronic myeloid leukemia with variant chromosomes"],"prefix":"10.1038","volume":"12","author":[{"family":"Anusha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitalakshmi","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2215-9042","authenticated-orcid":false,"given":"Snijesh","family":"V. P.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya A.","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnamurthy","family":"H.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharat","family":"Damodar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-5751","authenticated-orcid":false,"given":"Neha","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"3542_CR1","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.1182\/blood-2011-01-328294","volume":"117","author":"G Marzocchi","year":"2011","unstructured":"Marzocchi, G. et al. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood 117, 6793\u20136800 (2011).","journal-title":"Blood"},{"key":"3542_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/02841861003660031","volume":"49","author":"F Stagno","year":"2010","unstructured":"Stagno, F. et al. Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Acta Oncol. 49, 506\u2013508 (2010).","journal-title":"Acta Oncol."},{"key":"3542_CR3","first-page":"1333","volume":"9","author":"AN Mohamed","year":"2003","unstructured":"Mohamed, A. N., Pemberton, P., Zonder, J. & Schiffer, C. A. The effect of imatinib mesylate on patients with philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin. Cancer Res. 9, 1333\u20131337 (2003).","journal-title":"Clin. Cancer Res."},{"key":"3542_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fonc.2019.00088","volume":"9","author":"R Krishna Chandran","year":"2019","unstructured":"Krishna Chandran, R. et al. Impact of additional chromosomal aberrations on the disease progression of chronic myelogenous leukemia. Front. Oncol. 9, 88 (2019).","journal-title":"Front. Oncol."},{"key":"3542_CR5","first-page":"142","volume":"30","author":"H Menon","year":"2017","unstructured":"Menon, H. Non-adherence to CML therapy and its clinical implications in India YR - 2017\/5\/1. Natl Med. J. India 30, 142\u2013147 (2017).","journal-title":"Natl Med. J. India"},{"key":"3542_CR6","first-page":"64","volume":"3","author":"P Ganesan","year":"2016","unstructured":"Ganesan, P. & Kumar, L. Chronic myeloid leukemia in India 3, 64\u201371 (2016).","journal-title":"Chronic myeloid leukemia in India"},{"key":"3542_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/0971-5851.123711","volume":"34","author":"S Bansal","year":"2013","unstructured":"Bansal, S., Prabhash, K. & Parikh, P. Chronic myeloid leukemia data from India. Indian J. Med. Paediatr. Oncol. 34, 154\u2013158 (2013).","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"3542_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/2278-330X.187593","volume":"5","author":"MK Singhal","year":"2016","unstructured":"Singhal, M. K., Sengar, M. & Nair, R. Summary of the published Indian data on chronic myeloid leukemia. South Asian J. Cancer 5, 162\u2013165 (2016).","journal-title":"South Asian J. Cancer"},{"key":"3542_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12185-008-0230-0","volume":"89","author":"WY Au","year":"2009","unstructured":"Au, W. Y. et al. Chronic myeloid leukemia in Asia. Int. J. Hematol. 89, 14\u201323 (2009).","journal-title":"Int. J. Hematol."},{"key":"3542_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks, C. et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on hedgehog pathway activation. Cancer Cell 14, 238\u2013249 (2008).","journal-title":"Cancer Cell"},{"key":"3542_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao, C. et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776\u2013779 (2009).","journal-title":"Nature"},{"key":"3542_CR12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm1614","volume":"13","author":"C Dierks","year":"2007","unstructured":"Dierks, C. et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat. Med. 13, 944\u2013951 (2007).","journal-title":"Nat. Med."},{"key":"3542_CR13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.cellsig.2012.05.015","volume":"24","author":"PF Seke Etet","year":"2012","unstructured":"Seke Etet, P. F., Vecchio, L., Nwabo & Kamdje, A. H. Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment. Cell. Signal. 24, 1883\u20131888 (2012).","journal-title":"Cell. Signal."},{"key":"3542_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-9966-30-8","volume":"30","author":"B Long","year":"2011","unstructured":"Long, B., Zhu, H., Zhu, C., Liu, T. & Meng, W. Activation of the Hedgehog pathway in chronic myelogeneous leukemia patients. J. Exp. Clin. Cancer Res. 30, 8 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3542_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.biopha.2011.12.008","volume":"66","author":"HF Liao","year":"2012","unstructured":"Liao, H. F. et al. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells. Biomed. Pharmacother. 66, 378\u2013383 (2012).","journal-title":"Biomed. Pharmacother."},{"key":"3542_CR16","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-12-1777","volume":"19","author":"S Katagiri","year":"2013","unstructured":"Katagiri, S. et al. Combination of ponatinib with hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia. Clin. Cancer Res. 19, 1422\u20131432 (2013).","journal-title":"Clin. Cancer Res."},{"key":"3542_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep25476","volume":"6","author":"DA Irvine","year":"2016","unstructured":"Irvine, D. A. et al. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci. Rep. 6, 25476 (2016).","journal-title":"Sci. Rep."},{"key":"3542_CR18","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.4161\/cc.9.17.12945","volume":"9","author":"Z Jagani","year":"2010","unstructured":"Jagani, Z., Dorsch, M. & Warmuth, M. Hedgehog pathway activation in chronic myeloid leukemia: a promise for a novel combination therapeutic approach? Cell Cycle 9, 3449\u20133456 (2010).","journal-title":"Cell Cycle"},{"key":"3542_CR19","doi-asserted-by":"publisher","unstructured":"Branford, S. et al. Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease. Blood 2018. https:\/\/doi.org\/10.1182\/blood-2018-02-832253.","DOI":"10.1182\/blood-2018-02-832253"},{"key":"3542_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."},{"key":"3542_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1126\/science.1139740","volume":"317","author":"R Rohatgi","year":"2007","unstructured":"Rohatgi, R., Milenkovic, L. & Scott, M. P. Patched1 regulates hedgehog signaling at the primary cilium. Science 317, 372\u2013376 (2007).","journal-title":"Science"},{"key":"3542_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nature04117","volume":"437","author":"KC Corbit","year":"2005","unstructured":"Corbit, K. C. et al. Vertebrate Smoothened functions at the primary cilium. Nature 437, 1018\u20131021 (2005).","journal-title":"Nature"},{"key":"3542_CR23","doi-asserted-by":"publisher","first-page":"7947","DOI":"10.1158\/0008-5472.CAN-04-0945","volume":"64","author":"PJ Real","year":"2004","unstructured":"Real, P. J. et al. Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2. Cancer Res. 64, 7947\u20137953 (2004).","journal-title":"Cancer Res."},{"key":"3542_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep07357","volume":"4","author":"N Vyas","year":"2014","unstructured":"Vyas, N. et al. Vertebrate Hedgehog is secreted on two types of extracellular vesicles with different signaling properties. Sci. Rep. 4, 7357 (2014).","journal-title":"Sci. Rep."},{"key":"3542_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tcb.2017.10.003","volume":"28","author":"A Parchure","year":"2018","unstructured":"Parchure, A., Vyas, N., & Mayor, S. Wnt and Hedgehog: secretion of lipid-modified morphogens. Trends Cell Biol. 28, 157\u2013170 (2018).","journal-title":"Trends Cell Biol."},{"key":"3542_CR26","first-page":"315","volume":"4","author":"TI Mughal","year":"2010","unstructured":"Mughal, T. I. & Schrieber, A. Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase. Biologics. 4, 315\u2013323 (2010).","journal-title":"Biologics."},{"key":"3542_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10871-0","volume":"10","author":"E Peterman","year":"2019","unstructured":"Peterman, E. et al. The post-abscission midbody is an intracellular signaling organelle that regulates cell proliferation. Nat. Commun. 10, 3181 (2019).","journal-title":"Nat. Commun."},{"key":"3542_CR28","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1083\/jcb.201906148","volume":"218","author":"E Peterman","year":"2019","unstructured":"Peterman, E. & Prekeris, R. The postmitotic midbody: regulating polarity, stemness, and proliferation. J. Cell Biol. 218, 3903\u20133911 (2019).","journal-title":"J. Cell Biol."},{"key":"3542_CR29","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1242\/jcs.172635","volume":"128","author":"L Vuolo","year":"2015","unstructured":"Vuolo, L., Herrera, A., Torroba, B., Menendez, A. & Pons, S. Ciliary adenylyl cyclases control the Hedgehog pathway. J. Cell Sci. 128, 2928\u20132937 (2015).","journal-title":"J. Cell Sci."},{"key":"3542_CR30","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1242\/dev.051714","volume":"137","author":"C Cruz","year":"2010","unstructured":"Cruz, C. et al. Foxj1 regulates floor plate cilia architecture and modifies the response of cells to sonic hedgehog signalling. Development 137, 4271\u20134282 (2010).","journal-title":"Development"},{"key":"3542_CR31","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.diff.2011.11.010","volume":"83","author":"S Roy","year":"2012","unstructured":"Roy, S. Cilia and Hedgehog: when and how was their marriage solemnized? Differentiation 83, S43\u2013S48 (2012).","journal-title":"Differentiation"},{"key":"3542_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12860-020-00266-1","volume":"21","author":"N Venugopal","year":"2020","unstructured":"Venugopal, N. et al. The primary cilium dampens proliferative signaling and represses a G2\/M transcriptional network in quiescent myoblasts. BMC Mol. Cell Biol. 21, 25 (2020).","journal-title":"BMC Mol. Cell Biol."},{"key":"3542_CR33","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.celrep.2019.11.015","volume":"29","author":"J Ferent","year":"2019","unstructured":"Ferent, J. et al. The ciliary protein Arl13b functions outside of the primary cilium in Shh-mediated axon guidance. Cell Rep. 29, 3356\u20133366.e3 (2019).","journal-title":"Cell Rep."},{"key":"3542_CR34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/leu.2011.285","volume":"26","author":"DH Mak","year":"2012","unstructured":"Mak, D. H. et al. Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors. Leukemia 26, 788\u2013794 (2012).","journal-title":"Leukemia"},{"key":"3542_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.exphem.2012.01.003","volume":"40","author":"W Su","year":"2012","unstructured":"Su, W. et al. Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through \u03b2-catenin signaling. Exp. Hematol. 40, 418\u2013427 (2012).","journal-title":"Exp. Hematol."},{"key":"3542_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.molonc.2010.06.001","volume":"4","author":"MAG Essers","year":"2010","unstructured":"Essers, M. A. G. & Trumpp, A. Targeting leukemic stem cells by breaking their dormancy. Mol. Oncol. 4, 443\u2013450 (2010).","journal-title":"Mol. Oncol."},{"key":"3542_CR37","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","volume":"5","author":"DJ Barnes","year":"2006","unstructured":"Barnes, D. J. & Melo, J. V. Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle 5, 2862\u20132866 (2006).","journal-title":"Cell Cycle"},{"key":"3542_CR38","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1074\/jbc.M310589200","volume":"279","author":"RLH Bigelow","year":"2004","unstructured":"Bigelow, R. L. H. et al. Transcriptional regulation of bcl-2 mediated by the Sonic hedgehog signaling pathway through gli-1. J. Biol. Chem. 279, 1197\u20131205 (2004).","journal-title":"J. Biol. Chem."},{"key":"3542_CR39","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-04-1085","volume":"64","author":"G Regl","year":"2004","unstructured":"Regl, G. et al. Activation of the BCL2 promoter in response to hedgehog\/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 64, 7724\u20137731 (2004).","journal-title":"Cancer Res."},{"key":"3542_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1242\/dev.02228","volume":"133","author":"J Cayuso","year":"2006","unstructured":"Cayuso, J., Ulloa, F., Cox, B., Briscoe, J. & Mart\u00ed, E. The Sonic hedgehog pathway independently controls the patterning, proliferation and survival of neuroepithelial cells by regulating Gli activity. Development 133, 517\u2013528 (2006).","journal-title":"Development"},{"key":"3542_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exphem.2018.02.002","volume":"61","author":"J Mihalyova","year":"2018","unstructured":"Mihalyova, J. et al. Venetoclax: a new wave in hematooncology. Exp. Hematol. 61, 10\u201325 (2018).","journal-title":"Exp. Hematol."},{"key":"3542_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/cdd.2017.161","volume":"25","author":"JM Adams","year":"2018","unstructured":"Adams, J. M. & Cory, S. The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death Differ. 25, 27\u201336 (2018).","journal-title":"Cell Death Differ."},{"key":"3542_CR43","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.stemcr.2018.01.015","volume":"10","author":"M Miyauchi","year":"2018","unstructured":"Miyauchi, M. et al. ADAM8 is an antigen of tyrosine kinase inhibitor-resistant chronic myeloid leukemia cells identified by patient-derived induced pluripotent stem cells. Stem Cell Rep. 10, 1115\u20131130 (2018).","journal-title":"Stem Cell Rep."},{"key":"3542_CR44","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.devcel.2011.05.010","volume":"20","author":"S Ohlig","year":"2011","unstructured":"Ohlig, S. et al. Sonic hedgehog shedding results in functional activation of the solubilized protein. Developmental Cell 20, 764\u2013774 (2011).","journal-title":"Developmental Cell"},{"key":"3542_CR45","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.1074\/jbc.M806838200","volume":"284","author":"T Dierker","year":"2009","unstructured":"Dierker, T., Dreler, R., Petersen, A., Bordych, C. & Grobe, K. Heparan sulfate-modulated, metalloprotease-mediated sonic hedgehog release from producing cells. J. Biol. Chem. 284, 8013\u20138022 (2009).","journal-title":"J. Biol. Chem."},{"key":"3542_CR46","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1242\/jcs.137695","volume":"127","author":"P Jakobs","year":"2014","unstructured":"Jakobs, P. et al. Scube2 enhances proteolytic Shh processing from the surface of Shh-producing cells. J. Cell Sci. 127, 1726\u20131737 (2014).","journal-title":"J. Cell Sci."},{"key":"3542_CR47","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1182\/blood-2013-03-490003","volume":"121","author":"Experts in Chronic Myeloid Leukemia.","year":"2013","unstructured":"Experts in Chronic Myeloid Leukemia. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood 121, 4439\u20134442 (2013).","journal-title":"Blood"},{"key":"3542_CR48","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1182\/blood-2009-09-241943","volume":"115","author":"A K\u00fchnl","year":"2010","unstructured":"K\u00fchnl, A. et al. High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood 115, 3737\u20133744 (2010).","journal-title":"Blood"},{"key":"3542_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"3542_CR50","doi-asserted-by":"crossref","unstructured":"Smyth G. K. limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor (eds Gentleman, R., Carey, V. J., Huber, W., Irizarry, R. A., Dudoit, S.) (Springer New York: New York, NY, 2005, pp. 397\u2013420).","DOI":"10.1007\/0-387-29362-0_23"},{"key":"3542_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249\u2013264 (2003).","journal-title":"Biostatistics"},{"key":"3542_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2014analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03542-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03542-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03542-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:35:20Z","timestamp":1669919720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03542-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["3542"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03542-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institute Review Board (IRB Min. No. NHH\/AEC-CL-2017-172, dated January 9, 2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"CML patient\u2019s BM samples were collected prior to treatment as a part of routine diagnostic requirement, a part of this sample was used for the study, after taking written and informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"259"}}